Cargando…
A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi
In this study, we evaluated the long-term efficacy of a two-component subunit vaccine against Trypanosoma cruzi infection. C57BL/6 mice were immunized with TcG2/TcG4 vaccine delivered by a DNA-prime/Protein-boost (D/P) approach and challenged with T. cruzi at 120 or 180 days post-vaccination (dpv)....
Autores principales: | Gupta, Shivali, Garg, Nisha J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423834/ https://www.ncbi.nlm.nih.gov/pubmed/25951312 http://dx.doi.org/10.1371/journal.ppat.1004828 |
Ejemplares similares
-
Testing the Efficacy of a Multi-Component DNA-Prime/DNA-Boost Vaccine
against Trypanosoma cruzi Infection in Dogs
por: Aparicio-Burgos, José E., et al.
Publicado: (2011) -
Prophylactic Efficacy of TcVac2 against Trypanosoma cruzi in Mice
por: Gupta, Shivali, et al.
Publicado: (2010) -
TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice
por: Gupta, Shivali, et al.
Publicado: (2013) -
Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
por: Sanchez Alberti, Andrés, et al.
Publicado: (2020) -
Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus
por: Calvo-Pinilla, Eva, et al.
Publicado: (2012)